JPRN-UMIN000039226已完成未知
Characterizing the cross-sectional approach to investigate the prevalence of tissue BRCA1/2 mutations in newly diagnosed advanced ovarian cancer patients - Characterizing the cross-sectional approach to investigate the prevalence of tissue BRCA1/2 mutations in newly diagnosed advanced ovarian cancer patients(CHRISTELLE Study)
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 206
研究概览
简要总结
This study was conducted in 20 study sites in Japan and included patients with newly diagnosed OC of FIGO stage III and IV.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Patients who are not recommended enrolling this study decided by study investigator
研究者
相似试验
已完成
不适用
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer PatientsOvarian NeoplasmsNCT04222465AstraZeneca207
已完成
不适用
International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)AsthmaNCT01567280Chiesi Farmaceutici S.p.A.8,111
已完成
不适用
Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCAOvarian CancerNCT03229122AstraZeneca446
已完成
不适用
Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII DeficiencyCongenital Bleeding DisorderCongenital FVII DeficiencyNCT01312636Novo Nordisk A/S36
已完成
2 期
Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)Carcinoma of the Head and NeckNCT00865098Merck KGaA, Darmstadt, Germany27